[email protected]
CDI - Contrive Datum Insights
Medical Devices

Radiation Oncology MarketSize, Share & Industry Analysis, 2026-2034By Treatment ModalityBy TechniqueBy Product and Service OfferingBy Cancer TypeBy Treatment IntentBy Fractionation RegimenBy End UserBy Patient Age GroupBy Procurement Model

Full title & scope — all 9 axes with their segments

Radiation Oncology Market Size, Share & Industry Analysis, By Treatment Modality (External Beam Radiation Therapy, Proton Therapy, Carbon Ion Therapy, Brachytherapy, Systemic Radioisotope Therapy, Intraoperative Radiotherapy), By Technique (3D Conformal Radiotherapy, Intensity-Modulated Radiotherapy, Volumetric Modulated Arc Therapy, Image-Guided Radiotherapy, Stereotactic Radiotherapy, Adaptive Radiotherapy), By Product and Service Offering (Treatment Delivery Systems, Treatment Planning Software, Oncology Information Systems, Patient Positioning and Immobilization, Quality Assurance and Dosimetry, Radioisotopes and Sealed Sources, Installation, Maintenance and Upgrade Services), By Cancer Type (Prostate Cancer, Breast Cancer, Lung Cancer, Head and Neck Cancer, Colorectal Cancer, Brain and Central Nervous System Tumors, Gynecological Cancer, Other Cancers), By Treatment Intent (Curative, Adjuvant, Neoadjuvant, Palliative), By Fractionation Regimen (Conventional Fractionation, Moderate Hypofractionation, Ultra-Hypofractionation, Hyperfractionation, Accelerated Fractionation), By End User (Hospitals, Independent Radiotherapy Centers, Cancer Research Institutes, Ambulatory Oncology Clinics), By Patient Age Group (Pediatric, Adult, Geriatric), By Procurement Model (Outright Purchase, Leasing and Equipment-as-a-Service, Per-Procedure or Managed Service Contracts, Public Tender and Government Procurement), and Regional Forecast, 2026-2034

Last Updated: Nov 18, 2026Format: PDFReport ID: CDI-248917
Segmentation

Segment definitions and share of revenue by product, animal, end user and region.

Segmented by
Treatment Modality
Technique
Product And Service Offering
Cancer Type
Treatment Intent
Fractionation Regimen
End User
Patient Age Group
Procurement Model
Structure

Segmentation Analysis

9 axes

By Treatment Modality

6
  • 01External Beam Radiation Therapy
  • 02Proton Therapy
  • 03Carbon Ion Therapy
  • 04Brachytherapy
  • 05Systemic Radioisotope Therapy
  • 06Intraoperative Radiotherapy

By Technique

6
  • 013D Conformal Radiotherapy
  • 02Intensity-Modulated Radiotherapy
  • 03Volumetric Modulated Arc Therapy
  • 04Image-Guided Radiotherapy
  • 05Stereotactic Radiotherapy
  • 06Adaptive Radiotherapy

By Product and Service Offering

7
  • 01Treatment Delivery Systems
  • 02Treatment Planning Software
  • 03Oncology Information Systems
  • 04Patient Positioning and Immobilization
  • 05Quality Assurance and Dosimetry
  • 06Radioisotopes and Sealed Sources
  • 07Installation, Maintenance and Upgrade Services

By Cancer Type

8
  • 01Prostate Cancer
  • 02Breast Cancer
  • 03Lung Cancer
  • 04Head and Neck Cancer
  • 05Colorectal Cancer
  • 06Brain and Central Nervous System Tumors
  • 07Gynecological Cancer
  • 08Other Cancers

By Treatment Intent

4
  • 01Curative
  • 02Adjuvant
  • 03Neoadjuvant
  • 04Palliative

By Fractionation Regimen

5
  • 01Conventional Fractionation
  • 02Moderate Hypofractionation
  • 03Ultra-Hypofractionation
  • 04Hyperfractionation
  • 05Accelerated Fractionation

By End User

4
  • 01Hospitals
  • 02Independent Radiotherapy Centers
  • 03Cancer Research Institutes
  • 04Ambulatory Oncology Clinics

By Patient Age Group

3
  • 01Pediatric
  • 02Adult
  • 03Geriatric

By Procurement Model

4
  • 01Outright Purchase
  • 02Leasing and Equipment-as-a-Service
  • 03Per-Procedure or Managed Service Contracts
  • 04Public Tender and Government Procurement

Segment categories shown for scope reference. See the Summary tab for revenue share by Treatment Modality. Full segment-by-segment detail across every axis is available in the sample and full report.

Scope

Questions This Report Answers

6 questions
01

What is the market size and growth rate, globally and by region?

02

How is the market segmented, and which segments lead?

03

Which regions and countries are covered, and how do they compare?

04

What are the key drivers, restraints, opportunities and challenges?

05

Who are the leading companies operating in this market?

06

What trends are expected to shape the market through the forecast period?

Questions

Frequently Asked Questions

01What is the Radiation Oncology Market projected to reach?

USD 18.7 USD Billion by 2034, CAGR 7.48%

02What years does this report cover?

Study period 2020–2034, base year 2025, historical data 2020-2024, forecast period 2026-2034.

03Which regions are covered?

North America, Europe, Asia Pacific, Latin America, Middle East and Africa.

04Which region accounted for the largest market share?

North America leads with 41% of global revenue through 2034.

05Which segment leads the market?

External Beam Radiation Therapy is the largest line by treatment modality, at 72% of revenue in 2025.

06Who are the key companies profiled?

Siemens Healthineers AG (Varian Medical Systems, Inc.), Elekta AB, Accuray Incorporated, Ion Beam Applications S.A. (IBA), Hitachi, Ltd., Sumitomo Heavy Industries, Ltd., Mevion Medical Systems, Inc., Brainlab AG, RaySearch Laboratories AB, Mirion Technologies, Inc. (Sun Nuclear), Eckert & Ziegler SE, Novartis AG, Bayer AG, Perspective Therapeutics, Inc., Theragenics Corporation, CIVCO Medical Solutions, Best Medical International, Inc., PTW-Freiburg GmbH, Standard Imaging, Inc., Reflexion Medical, Inc., Our United Corporation, Shinva Medical Instrument Co., Ltd., ProTom International Holding Corp., Leo Cancer Care, Inc., ZAP Surgical Systems, Inc., iCAD, Inc.. Full profiles are part of the paid report.

07Can the segmentation be customized?

Yes. Custom data cuts by geography, segment, or competitor set are available on request.

425+
Dedicated research analysts
1,200+
Reports published
Why CDI

Why choose CDI

Data triangulated across primary and secondary sources
Complimentary analyst call included with every purchase
Custom data cuts and post-purchase support available

Need this report shaped around your question?

The scope isn't fixed. Tell us what your team needs that the standard edition doesn't cover, and an analyst will come back on what can be adjusted and how long it takes, before you commit to anything.

Most licences include 30–60 hours of customization at no extra cost. See what each licence includes

Request customization

Additional Companies

Add competitors, suppliers or the peer set you benchmark against to the companies already covered.

Deeper Competitive View

Sharpen the landscape work around your own position: product line, channel, or a named shortlist of rivals.

Extra Segment Splits

Break the market down along an axis the standard scope doesn't cut it by, or go a level deeper inside one.

Application Focus

Narrow the analysis to the specific use cases and end users your team actually sells into.

Different Time Frame

Move the base year, or widen the historical and forecast windows the study is built on.

Country-Level Detail

Go below region level into the individual countries that matter to you, rather than the standard geography split.